Key EventAppellate order allows appeal against income tax demand
Key EventGufic BioSciences receives Crisil ESG rating of 62 (Strong) for FY 2025-26
ImpactThe ESG rating validates Gufic's sustainability efforts and may enhance its appeal to ESG-focused investors.Sign up to read impact
Key EventTrading window closure announced for Gufic BioSciences
Gufic BioSciences Ltd (GUFICBIO)
Β·Next Day CloseΒ·+0.39%Β·βΉ422.9
Key EventNSE rejects waiver application for director age compliance penalty
Gufic BioSciences Ltd (GUFICBIO)
Β·Next Day CloseΒ·-2.13%Β·βΉ430.2
Key EventCRISIL reaffirmed and upgraded Gufic BioSciences' credit ratings.
ImpactThe rating reaffirmation signals stable credit health and supports continued access to financing.Sign up to read impact
Gufic BioSciences Ltd (GUFICBIO)
Β·Next Day CloseΒ·+0.35%Β·βΉ446.95
Key EventGufic Biosciences approved FY2026 financials and declared a final dividend of Re. 0.10 per share.
ImpactThe dividend signals confidence in cash flow, while director reappointment ensures continuity in leadership.Sign up to read impact
Gufic BioSciences Ltd (GUFICBIO)
Β·Next Day CloseΒ·+0.23%Β·βΉ440.25
Key EventPromotion of Ms. Ami Shah to Head-Legal and Mr. Pinak Padhya to President-Sales & Marketing.
ImpactThese promotions signal leadership continuity and expanded expertise in legal and sales functions, potentially supporting future growth.Sign up to read impact
Gufic Biosciences Limited (GUFICBIO)
Β·Next Day CloseΒ·+0.72%Β·βΉ420.65
Key EventAudio recording of earnings call uploaded
ImpactInvestors can now listen to the call audio to assess managementβs commentary and performance insights.Sign up to read impact
Gufic Biosciences Limited (GUFICBIO)
Β·Next Day CloseΒ·-0.84%Β·βΉ417.65
Key EventBoard approves incorporation of Philippine subsidiary and cash investment up to USD 250,000
ImpactThis creates a new growth avenue in Southeast Asia through a wholly owned subsidiary.Sign up to read impact
Gufic Biosciences Limited (GUFICBIO)
Β·Next Day CloseΒ·-0.84%Β·βΉ417.65
Key EventBoard approved Q1 FY27 results and Philippine subsidiary incorporation
ImpactThe Philippine expansion targets Southeast Asian market growth through localized distribution and IP control.Sign up to read impact